Supernus Pharmaceuticals | SUPN - Interest Income


Supernus Pharmaceuticals reported $4.53M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Abbott USD 77M 6M Sep/2025
Aurora Cannabis CAD 1.85M 120K Sep/2025
Corcept Therapeutics USD 5.02M 1.18M Jun/2025
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Pacira USD 5.01M 1.89M Jun/2025
Pfizer USD 0.62 156M Sep/2025
Supernus Pharmaceuticals USD 4.53M 103K Jun/2025
United Therapeutics USD 51.3M 200K Jun/2025
Xeris Pharmaceuticals USD 1.16M 210K Sep/2025